Trial NCT04456023

View at ClinicalTrials.gov 
Org. Study IDs: CCTL019C2203

Last trial update was posted on 2022-03-02

MeSH Interventions

Tisagenlecleucel

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin

Other Conditions

Diffuse Large B-Cell Lymphoma (DLBCL)

Stopping Reasons

This study was cancelled before enrolling any patients for business related reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID